BIOLOGIC CHOICES AFTER FIRST-LINE ANTI-TUMOUR NECROSIS FACTOR FAILURE IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

被引：0
|
作者：
Richards, H. [1 ]
Baildam, E. [1 ]
McCann, L. J. [1 ]
Cleary, A. G. [1 ]
Beresford, M. W. [1 ]
Pain, C. E. [1 ]
机构：
[1] Alder Hey Childrens NHS Fdn Trust, Dept Rheumatol, Liverpool, Merseyside, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
21
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis
    Yamasaki, Yuichi
    Nakamura, Aki
    Kubota, Tomohiro
    Mitsunobu, Takuro
    Moriyama, Mizuki
    Takei, Syuji
    Okamoto, Yasuhiro
    MODERN RHEUMATOLOGY, 2023, 33 (06) : 1171 - 1175
  • [2] Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis
    Tynjala, P.
    Vahasalo, P.
    Honkanen, V.
    Lahdenne, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) : 552 - 557
  • [3] DRUG SURVIVAL OF SECOND BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON OF A SECOND ANTI-TUMOUR NECROSIS FACTOR WITH A SECOND NON-ANTI-TUMOUR NECROSIS FACTOR AFTER DISCONTINUATION OF A FIRST ANTI-TUMOUR NECROSIS FACTOR
    Wilke, Thomas
    Mueller, Sabrina
    Majer, Istvan
    Heisen, Marieke
    Fuchs, Andreas
    Maywald, Ulf
    RHEUMATOLOGY, 2016, 55 : 105 - 105
  • [4] Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis
    Barber, J
    Sheeran, T
    Mulherin, D
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (05) : 490 - 491
  • [5] Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
    Pedersen, Mia Lindegaard
    Neve-Graesboll, Amalie
    Herlin, Troels
    Glerup, Mia
    PEDIATRIC RHEUMATOLOGY, 2023, 21 (01)
  • [6] Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
    Mia Lindegaard Pedersen
    Amalie Neve-Græsbøll
    Troels Herlin
    Mia Glerup
    Pediatric Rheumatology, 21
  • [7] EVALUATION OF DURATION OF CLINICAL REMISSION IN CHILDREN WITH NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS AFTER WITHDRAWAL OF ANTI - TUMOR NECROSIS FACTOR - ALPHA THERAPY
    Tsulukiya, I.
    Alexeeva, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Denisova, R.
    Lomakina, O.
    Mamutova, A.
    Chomakhidze, A.
    Fetisova, A.
    Gautier, M.
    Kriulin, I.
    Krekhova, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 250 - 250
  • [8] Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
    C Rivarola
    C Hovhannessian
    A Duquesne
    R Cimaz
    Pediatric Rheumatology, 6 (Suppl 1)
  • [9] Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency
    Kilic, SS
    JOURNAL OF TROPICAL PEDIATRICS, 2005, 51 (03) : 194 - 195
  • [10] ANTI-TUMOUR NECROSIS FACTOR (ATNF) WEANING STRATEGY IN JUVENILE IDIOPATHIC ARTHRITIS (JIA): DOES LONGER DURATION MATTER?
    Arkachaisri, T.
    Teh, K. L.
    Book, Y. X.
    Gao, X.
    Das., L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 424 - 425
12345